Catalyst Pharmaceutical Partners Inc buy Robert W. Baird
Start price
03.03.25
/
50%
€22.15
Target price
03.03.26
€30.55
Performance (%)
-8.80%
Price
18.12.25
€20.20
Summary
This prediction is currently active. With a performance of -8.80%, the BUY prediction by Robert_W__Baird is trending in the wrong direction. This prediction currently runs until 03.03.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.404% | 3.404% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Robert_W__Baird for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Robert W. Baird from $28.00 to $32.00. They now have an "outperform" rating on the stock.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by Robert_W__Baird for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€22.14
04.02.25
04.02.25
€27.08
04.02.26
04.02.26
-8.76%
18.12.25
18.12.25
